Harvard Bioscience (HBIO)
Builds research tools for preclinical and cellular-and-molecular science.
$7.92
After hours−0.03 (−0.38%)
At close$7.95(−0.63%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.17
Revenue estimate
$21.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.60−$0.10−$0.10−$0.28−$0.64−$0.33−$0.14Pending
Estimate$0.07−$0.20−$0.25$0.05$0.04−$0.62−$0.21−$0.17
Surprise+757.1%+50.0%+60.0%−652.0%−1,700.0%+46.8%+33.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$24.6M$21.8M$20.5M$20.6M$23.7M$20.8M$22.7MPending
Estimate$24.2M$19.2M$18.8M$20.0M$23.1M$21.2M$21.5M$21.8M
Surprise+1.7%+13.4%+9.1%+3.0%+2.7%−2.1%+6.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.48 | — | — |
| Sep 2027 | $0.30 | — | — |
| Jun 2027 | $0.13 | — | — |
| Mar 2027 | −$0.01 | — | — |
| Dec 2026 | $0.23 | — | — |
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$0.21 | −$0.14 | +33.3% |
| May 2026 | −$0.62 | −$0.33 | +46.8% |
| Mar 2026 | $0.04 | −$0.64 | −1,700.0% |
| Nov 2025 | $0.05 | −$0.28 | −652.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Mar 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Dec 2015 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.48 | — | — | $25.5M | — | — | — |
| Sep 2027 | $0.30 | — | — | $22.6M | — | — | — |
| Jun 2027 | $0.13 | — | — | $23.7M | — | — | — |
| Mar 2027 | −$0.01 | — | — | $21.8M | — | — | — |
| Dec 2026 | $0.23 | — | — | $24.5M | — | — | — |
| Nov 5, 2026 | −$0.17 | — | — | $21.8M | — | — | — |
| Aug 11, 2026 | −$0.21 | −$0.14 | +33.3% | $21.5M | $22.7M | +6.0% | −4.1% |
| May 12, 2026 | −$0.62 | −$0.33 | +46.8% | $21.2M | $20.8M | −2.1% | −20.9% |
| Mar 12, 2026 | $0.04 | −$0.64 | −1,700.0% | $23.1M | $23.7M | +2.7% | −2.6% |
| Nov 6, 2025 | $0.05 | −$0.28 | −652.0% | $20.0M | $20.6M | +3.0% | −7.3% |
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 12, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| Apr 25, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 10, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 5, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Jul 25, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Oct 25, 2018 | |||||||
| Jul 26, 2018 | |||||||
| May 2, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Oct 26, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Mar 9, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jul 28, 2016 | |||||||
| May 12, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Oct 29, 2015 | |||||||
| Jul 30, 2015 |